You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

TESTOSTERONE CYPIONATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Testosterone Cypionate patents expire, and what generic alternatives are available?

Testosterone Cypionate is a drug marketed by Am Regent, Cipla, Eugia Pharma, Hikma, Hikma Farmaceutica, Padagis Us, Rising, Sandoz, Sun Pharm Inds Ltd, Watson Labs, Watson Pharms Inc, Wilshire Pharms Inc, Xiromed, and Azurity. and is included in sixteen NDAs. There are two patents protecting this drug.

The generic ingredient in TESTOSTERONE CYPIONATE is estradiol cypionate; testosterone cypionate. There are seventy-five drug master file entries for this compound. Additional details are available on the estradiol cypionate; testosterone cypionate profile page.

DrugPatentWatch® Generic Entry Outlook for Testosterone Cypionate

Indicators of Generic Entry

< Available with Subscription >

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TESTOSTERONE CYPIONATE?
  • What are the global sales for TESTOSTERONE CYPIONATE?
  • What is Average Wholesale Price for TESTOSTERONE CYPIONATE?
Drug patent expirations by year for TESTOSTERONE CYPIONATE
Drug Prices for TESTOSTERONE CYPIONATE

See drug prices for TESTOSTERONE CYPIONATE

Recent Clinical Trials for TESTOSTERONE CYPIONATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Phase 2
DendreonPhase 2
Yale UniversityPhase 2

See all TESTOSTERONE CYPIONATE clinical trials

Pharmacology for TESTOSTERONE CYPIONATE
Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists

US Patents and Regulatory Information for TESTOSTERONE CYPIONATE

TESTOSTERONE CYPIONATE is protected by two US patents.

Patents protecting TESTOSTERONE CYPIONATE

Pharmaceutical compositions of testosterone
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up


Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Am Regent TESTOSTERONE CYPIONATE testosterone cypionate INJECTABLE;INJECTION 207742-001 Jun 16, 2017 AO RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Pharms Inc TESTOSTERONE CYPIONATE testosterone cypionate INJECTABLE;INJECTION 086030-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE estradiol cypionate; testosterone cypionate INJECTABLE;INJECTION 085603-001 Mar 13, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.